Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
ABSTRACT In recent decades, carbapenems have been considered the last line of antibiotic therapy for Gram-negative bacterial infections. Unfortunately, strains carrying a high diversity of β-lactamases able to hydrolyze carbapenems have emerged in the clinical setting. Among them, VIM β-lactamases h...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
American Society for Microbiology
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c7e98d1d9a1843aa9ae8c889bf5f9b2d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|